← Back to Clinical Trials
Recruiting NCT06532422

NCT06532422 Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06532422
Status Recruiting
Phase
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition Kidney Cancer
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-12-13
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Partial or total laparoscopic nephrectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2024-12-13 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to compare to assess the incidence of post-operative complications related to nephrectomy, which occur up to 1 month after the operation.

Eligibility Criteria

Inclusion Criteria: * Patients over 18 ; * Localised kidney cancer ; * Validation of curative treatment at a multidisciplinary consultation meeting; * Partial or total laparoscopic nephrectomy scheduled on an outpatient basis; * Membership of a social security scheme or receiving State Medical Aid; * Patient able to understand the information relating to the study, to read the information leaflet and who has given his/her oral non-objection. Exclusion Criteria: * Emergency intervention ; * Patient not eligible for outpatient treatment; * Long-term curative anti-coagulant treatment ; * Resident more than 100km from the clinic; * Home alone on the first night; * Patient of protected age (under guardianship or curatorship, or deprived of liberty).

Contact & Investigator

Central Contact

Arnaud MD BALDINI

✉ docteur.baldini@urolyon-ouest.fr

📞 469001019

Frequently Asked Questions

Who can join the NCT06532422 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06532422 currently recruiting?

Yes, NCT06532422 is actively recruiting participants. Contact the research team at docteur.baldini@urolyon-ouest.fr for enrollment information.

Where is the NCT06532422 trial being conducted?

This trial is being conducted at Lyon, France.

Who is sponsoring the NCT06532422 clinical trial?

NCT06532422 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology